Skip to main content

ADC

Mirvetuximab Soravtansine
Ovarian Cancer Treatment

The Antibody Drug Conjugate Mirvetuximab soravtansine appears promising for treatment of certain patients with ovarian cancer.

By Dr. C.H. Weaver M.D.Mar 24, 2022